General Statement of Disclosure:

SPEAKER'S BUREAU: Alnylam(SIGNIFICANT), Astellas Pharma US(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Philips(SIGNIFICANT), General Electric(SIGNIFICANT)

View Full Disclosure